Efficacy and Safety of Taspoglutide Monotherapy in Drug-Naive Type 2 Diabetic Patients After 24 Weeks of Treatment: Results of a randomized, double-blind, placebo-controlled phase 3 study (T-emerge 1)

OBJECTIVE: To evaluate the efficacy and safety of taspoglutide monotherapy in drug-naive patients with type 2 diabetes inadequately controlled. RESEARCH DESIGN AND METHODS: In this 24-week double-blind, placebo-controlled, multicenter trial, 373 patients with type 2 diabetes naive to antihyperglycem...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Raz, Itamar, Fonseca, Vivian, Kipnes, Mark, Durrwell, Laurence, Hoekstra, John, Boldrin, Mark, Balena, Raffaella
Formato: Artigo
Idioma:Inglês
Publicado em: American Diabetes Association 2012
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3322710/
https://ncbi.nlm.nih.gov/pubmed/22301126
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc11-1942
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados